Streetbeat News

Stock Prices

CALX

Calix (NYSE:CALX) has received consistent 'Buy' ratings from analysts, with a stable 12-month price target of $45. Despite a decline in revenue growth, Calix maintains strong net margins and a sound financial structure. Analysts' evaluations provide insights into Calix's market standing.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 1:00 pm

CDNS

Cadence Design Systems (NASDAQ:CDNS) reported better-than-expected Q3 results, with earnings and sales surpassing analyst estimates. Despite this, shares fell 1.8%. Analysts revised their price targets, with Needham lowering to $315 and Baird raising to $340.

Portfolio Pulse from Avi Kapoor

October 29, 2024 | 12:57 pm

MCD

McDonald's executive reaffirms the company's outlook for the rest of the year, assuming no material impact from a recent E. Coli outbreak on its business.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:56 pm

SPY

The USA Redbook year-over-year growth rate increased to 5.6% from the previous 4.6%, indicating a rise in retail sales. This data can influence market sentiment and impact ETFs like SPY, which tracks the S&P 500 index.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:55 pm

LCID

Lucid Group announced it will open orders for its new Lucid Gravity SUV on November 7, 2024. The Grand Touring trim will start at $94,900, offering over 800 horsepower and a 440-mile range. Production is set to begin in late 2024, with the Touring model planned for late 2025.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:55 pm

MOVE

The trading halt status was updated at 8:55:00 AM ET, indicating a resumption of quotations. This update is crucial for investors tracking the affected securities.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:55 pm

AMKR

CHKP

CROX

CVI

DHI

DQ

HLIT

JBI

TMDX

XRX

Several major stocks, including TransMedics Group, CVR Energy, Xerox, Harmonic, Amkor Technology, Janus International, Crocs, Daqo New Energy, D.R. Horton, and Check Point Software, experienced significant declines in pre-market trading due to weak quarterly results and other financial disappointments.

Portfolio Pulse from Avi Kapoor

October 29, 2024 | 12:52 pm

NVS

Novartis AG reported strong Q3 earnings, with sales and EPS beating expectations. Key drugs like Cosentyx and Entresto showed significant growth. The company raised its 2024 guidance, expecting high teens growth in core operating income and low double-digit sales growth. Despite positive results, NVS stock is down 3.29% in premarket trading.

Portfolio Pulse from Vandana Singh

October 29, 2024 | 12:52 pm

JOBY

LRCX

NTAP

OKLO

QS

SU

Jim Cramer recommends buying Lam Research (LRCX) after it reported strong earnings, while advising to avoid QuantumScape (QS). He also comments on Suncor Energy (SU), Oklo (OKLO), Joby Aviation (JOBY), and NetApp (NTAP).

Portfolio Pulse from Avi Kapoor

October 29, 2024 | 12:52 pm

CHKP

Check Point Software Technologies reported a 7% revenue growth in Q3, with security subscriptions revenue up 11.5%. However, margins slipped due to rising expenses. The stock is down 7.69% premarket despite a 37% YTD gain.

Portfolio Pulse from Anusuya Lahiri

October 29, 2024 | 12:48 pm